Shandong Xinhua Pharmaceutical Company Limited Class H (XIN) Revenue
Shandong Xinhua Pharmaceutical Company Limited Class H Revenue
Shandong Xinhua Pharmaceutical Company Limited Class H had a revenue of 1.70B in the quarter ending Sep 30, 2026, with -11.58%. This bring the company's revenue in the last twelve months to 8.02B, Decreased 4.98%. In the fiscal year ending Dec 31, 2025, Shandong Xinhua Pharmaceutical Company Limited Class H had annual revenue of 8.75B with 3.41% growth.
- Revenue (ttm)
- 8.02B
- Revenue Growth
- -5.81%
- P/S Ratio
- 0.11
- Revenue/Employee
- EUR 1,209,216
- Employees
- 7,240
- Market Cap
- EUR 944.83M
Revenue Chart
Shandong Xinhua Pharmaceutical Company Limited Class H Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.75B | 288.41M | 3.41% |
| Dec 31, 2024 | 8.47B | 365.47M | 4.51% |
| Dec 31, 2023 | 8.10B | 597.86M | 7.97% |
| Dec 31, 2022 | 7.50B | 942.91M | 14.37% |
| Dec 31, 2021 | 6.56B | 554.49M | 9.23% |
| Dec 31, 2020 | 6.01B | 399.57M | 7.13% |
| Dec 31, 2019 | 5.61B | 398.15M | 7.65% |
| Dec 31, 2018 | 5.21B | 692.15M | 15.33% |
| Dec 31, 2017 | 4.52B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.